Healthy Outcomes: Navigating the 340B Drug Pricing Program for healthcare providers
A conversation with Sherri Faber, president and CEO of 340B Compliance Partners
On this episode of Healthy Outcomes, our host Mark Ross interviews Sherri Faber, president and CEO of 340B Compliance Partners. Together, they discuss the 340B Drug Pricing Program (340B Program), a federal government program created in 1992 that requires pharmaceutical manufacturers to provide outpatient pharmaceuticals to eligible healthcare providers and covered entities at discounted prices.
Topics of discussion include:
- History of the 340B Program
- Financial benefits for eligible healthcare providers participating in the 340B Program, specifically through cost savings and contract pharmacy arrangements
- Compliance requirements to participate in the 340B Program
- Regulatory oversight and monitoring of the 340B Program
- Strategies adopted by healthcare providers related to the 340B Program
- Future outlook of the 340B Program
Connect with us to hear more about our healthcare team.
About our host
Mark Ross
Mark Ross is a principal with Baker Tilly’s healthcare practice.
Sherri Faber, RPh, MHA
Sherri Faber is the president and CEO of 340B Compliance Partners and has nearly 30 years of experience in the healthcare industry. Prior to her current role, Sherri served as a director of pharmacy for more than a decade and is an Apexus 340B advanced operations certified expert, serving as a past speaker on 340B audits at a multi-state pharmacy conference.
Listen to this podcast now
Listen or subscribe to Healthy Outcomes on your favorite platform.
